CCL2 and breast cancer: Our data indicate the importance of evaluating CCR-2 expression in TEpCs as well as CCL-2 expression in TEpC and spindle-shaped stromal cells, because the pathways that produce CCR-2 and its ligands may provide targets for the prevention of breast cancer progression and metastasis [29].